Getting Practical About Optimizing Management of Stage II and III NSCLC: Expert Guidance to Elevate Care

episode

Previously titled “Perioperative Immunotherapy: A Multidisciplinary Blueprint for Optimizing Outcomes in Resectable NSCLC” — renamed by the publisher on Aug 4, 2026

0